Skip to main content
Premium Trial:

Request an Annual Quote

Microarray-based NIPT Firm CellScape Shuts Down

NEW YORK (GenomeWeb) – Microarray-based non-invasive prenatal testing firm CellScape has shut down.

According to its LinkedIn page, the company, which had been headquartered in Newark, Calif., ceased operations in September.

CellScape was founded in 2008 and was developing an NIPT using chromosomal microarrays for detecting fetal aneuploidies, as well as genetic disorders that generally have required invasive methods. In 2013, company officials told GenomeWeb Daily News that the firm planned to launch its test called Clarity in the second half of this year. That target date was later pushed back to 2015.

According to its LinkedIn page, CellScape had between 11 and 50 employees. Its founders were Karen Drexler, Bhairavi Parikh, and James Stone.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.